ABVC BIOPHARMA, INC. Quarterly Current State and Local Tax Expense (Benefit) in USD from Q1 2017 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Abvc Biopharma, Inc. annual/quarterly Current State and Local Tax Expense (Benefit) history and growth rate from Q1 2017 to Q3 2022.
  • Abvc Biopharma, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending September 30, 2022 was $800.000.
  • Abvc Biopharma, Inc. annual Current State and Local Tax Expense (Benefit) for 2022 was $2.4K, a 200% increase from 2021.
  • Abvc Biopharma, Inc. annual Current State and Local Tax Expense (Benefit) for 2021 was $800.000.
  • Abvc Biopharma, Inc. annual Current State and Local Tax Expense (Benefit) for 2018 was $1.85K, a 123% increase from 2017.
Current State and Local Tax Expense (Benefit), Quarterly (USD)
Current State and Local Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $800 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q1 2018 $1.85K +$1.02K +123% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-15
Q1 2017 $830 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.